Steven M Dudek Selected Research

phallacidin

8/2007

Regulation of hyperoxia-induced NADPH oxidase activation in human lung endothelial cells by the actin cytoskeleton and cortactin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven M Dudek Research Topics

Disease

22	Lung Injury 04/2022 - 08/2007
19	Acute Lung Injury 01/2022 - 08/2007
11	Inflammation (Inflammations) 12/2021 - 05/2005
9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 07/2013
7	Ventilator-Induced Lung Injury 04/2022 - 09/2008
6	Pneumonia (Pneumonitis) 04/2022 - 10/2010
6	Sepsis (Septicemia) 05/2015 - 04/2005
5	Asthma (Bronchial Asthma) 01/2022 - 12/2008
4	Neoplasms (Cancer) 01/2019 - 05/2015
3	Pulmonary Edema 01/2022 - 08/2013
3	Hypoxia (Hypoxemia) 01/2021 - 08/2013
3	Hyperoxia 05/2015 - 08/2007
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2022 - 10/2021
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 01/2022
2	COVID-19 01/2022 - 01/2021
2	Vascular Remodeling 01/2021 - 01/2021
2	Critical Illness (Critically Ill) 10/2013 - 12/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Pneumococcal Pneumonia 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Gaucher Disease (Gaucher's Disease) 01/2021
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Candidemia 01/2021
1	Diabetes Mellitus 11/2018
1	Parkinson Disease (Parkinson's Disease) 01/2017

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2011
8	LipopolysaccharidesIBA 04/2022 - 01/2011
7	Myosin-Light-Chain KinaseIBA 04/2022 - 12/2008
7	CortactinIBA 01/2022 - 08/2007
7	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2016 - 10/2010
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2008
4	CytokinesIBA 04/2022 - 08/2013
4	Nicotinamide PhosphoribosyltransferaseIBA 04/2022 - 09/2008
4	Protein Isoforms (Isoforms)IBA 04/2022 - 01/2011
4	SmokeIBA 03/2022 - 06/2014
4	Phosphotransferases (Kinase)IBA 01/2022 - 11/2003
4	EnzymesIBA 12/2021 - 07/2013
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 01/2011
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016 - 07/2013
4	Sphingosine-1-Phosphate ReceptorsIBA 03/2014 - 10/2010
3	Interleukin-6 (Interleukin 6)IBA 04/2022 - 01/2021
3	Small Interfering RNA (siRNA)IBA 12/2021 - 08/2007
3	Peptides (Polypeptides)IBA 01/2021 - 08/2007
3	Tyrosine (L-Tyrosine)FDA Link 04/2018 - 08/2007
3	Organophosphonates (Phosphonates)IBA 01/2016 - 07/2013
2	NF-kappa B (NF-kB)IBA 04/2022 - 01/2022
2	AlbuminsIBA 04/2022 - 01/2022
2	2- amino- 2- (2- (4- octylphenyl)ethyl)propane- 1,3- diol phosphonateIBA 01/2022 - 03/2014
2	Biological ProductsIBA 01/2022 - 01/2017
2	LigandsIBA 01/2022 - 01/2021
2	Microfilament Proteins (Actin Binding Proteins)IBA 01/2022 - 12/2008
2	EicosanoidsIBA 09/2021 - 05/2005
2	Phospholipases A2 (Phospholipase A2)IBA 01/2021 - 06/2009
2	Imatinib Mesylate (Gleevec)FDA Link 05/2020 - 12/2015
2	Pharmaceutical PreparationsIBA 01/2016 - 10/2015
2	Multifunctional EnzymesIBA 01/2015 - 06/2014
2	Therapeutic UsesIBA 03/2014 - 10/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2013 - 03/2011
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 03/2012 - 08/2007
2	Superoxides (Superoxide)IBA 03/2012 - 08/2007
2	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2012 - 08/2007
2	RNA (Ribonucleic Acid)IBA 12/2011 - 01/2011
2	SphingolipidsIBA 10/2011 - 10/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022
1	Chemotactic FactorsIBA 04/2022
1	MitogensIBA 04/2022
1	Coloring Agents (Dyes)IBA 04/2022
1	Evans Blue (Blue, Evans)FDA Link 04/2022
1	Cardiolipins (Cardiolipin)IBA 03/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2022
1	LipocalinsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2022
1	Hemin (Panhematin)FDA Link 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Streptococcus pneumoniae plY proteinIBA 12/2021
1	Dextrans (Dextran)FDA Link 12/2021
1	2- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA 12/2021
1	ImmunosorbentsIBA 12/2021
1	Secretory Phospholipases A2IBA 09/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	roxadustatIBA 01/2021
1	E-Cigarette VaporIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	EpitopesIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	LipidsIBA 01/2021
1	Nicotine FDA Link 01/2021
1	Prolyl-Hydroxylase InhibitorsIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 11/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2018
1	EndotoxinsIBA 01/2017

Therapy/Procedure

8	Therapeutics 01/2022 - 03/2011
6	Artificial Respiration (Mechanical Ventilation) 04/2022 - 08/2007
3	Mechanical Ventilators (Ventilator) 01/2021 - 08/2007
3	Radiotherapy 06/2016 - 03/2011
2	Ligation 10/2010 - 04/2005